InvestSMART

Regis Healthcare Limited (ASX: REG) - Announcements

Current share price for REG : $4.680 0.07 (1.52%)+

ASX company news and announcements for Regis Healthcare Limited (REG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Regis Healthcare Limited (REG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Regis Healthcare Limited (REG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Regis Healthcare Limited (REG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,416 Appendix 4G And Corporate Governance Statement 20 Sep 2018 2:09PM $2.950 $4.680 risen by 58.64%
$1,416 Annual Report to shareholders 20 Sep 2018 2:09PM $2.950 $4.680 risen by 58.64%
$1,416 Notice of Annual General Meeting/Proxy Form 20 Sep 2018 2:04PM $2.950 $4.680 risen by 58.64%
$1,416 Becoming a substantial holder from CBA 20 Sep 2018 1:25PM $2.955 $4.680 risen by 58.38%
$1,416 Regis Appendis 3B 13 Sep 2018 5:48PM $3.600 $4.680 risen by 30%
$1,416 Dividend/Distribution - REG 31 Aug 2018 9:49AM $3.550 $4.680 risen by 31.83%
$1,416 Regis Healthcare Investor Presentation FY2018 Results 31 Aug 2018 9:08AM $3.550 $4.680 risen by 31.83%
$1,416 Regis Healthcare Results Announcement FY2018 31 Aug 2018 9:02AM $3.550 $4.680 risen by 31.83%
$1,416 Regis Healthcare Appendix 4E and Financial Report FY2018 31 Aug 2018 8:59AM $3.550 $4.680 risen by 31.83%
$1,416 AGM Date 13 Aug 2018 10:50AM $3.380 $4.680 risen by 38.46%
$1,416 Notification of Annual Results FY18 Reporting Date 23 Jul 2018 12:19PM $3.485 $4.680 risen by 34.29%
$1,416 Final Director's Interest Notice 4 Jul 2018 9:39AM $3.360 $4.680 risen by 39.29%
$1,416 Presentation for the Macquarie Securities Conference 2018 2 May 2018 9:46AM $3.850 $4.680 risen by 21.56%
$1,416 Board Succession 19 Apr 2018 9:47AM $3.660 $4.680 risen by 27.87%
$1,416 Federal Court Judgement Update 8 Mar 2018 11:00AM $4.000 $4.680 risen by 17%
$1,416 Regis Healthcare Federal Court Judgment 2 Mar 2018 2:58PM $4.170 $4.680 risen by 12.23%
$1,416 Initial Director's Interest Notice 2 Mar 2018 9:50AM $4.140 $4.680 risen by 13.04%
$1,416 Initial Director's Interest Notice 2 Mar 2018 9:49AM $4.140 $4.680 risen by 13.04%
$1,416 Regis Healthcare Appointment of Non-Executive Directors 23 Feb 2018 9:12AM $3.800 $4.680 risen by 23.16%
$1,416 Dividend/Distribution - REG 23 Feb 2018 9:10AM $3.800 $4.680 risen by 23.16%
$1,416 Regis Healthcare Investor Presentation 1H FY18 Results 23 Feb 2018 9:07AM $3.800 $4.680 risen by 23.16%
$1,416 Regis Healthcare Results Announcement 1H FY18 23 Feb 2018 9:06AM $3.800 $4.680 risen by 23.16%
$1,416 Regis Healthcare 4D and Financial Report 1H FY18 23 Feb 2018 9:05AM $3.800 $4.680 risen by 23.16%
$1,416 Regis Half Year Results Reporting Date 23 Jan 2018 11:52AM $3.955 $4.680 risen by 18.33%
$1,416 Appendix 3B 18 Dec 2017 1:39PM $3.640 $4.680 risen by 28.57%

301 - 325 of 407 results

Page 13 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.